The challenge of curing high-risk neuroblastoma
This Neuroblastoma Parent Symposium recorded session covers a wide range of subjects that at the time of recording in 2022 were being researched. Prof. Jan Molenaar gives an introduction to precision medicines and how new targets are identified. Dr. Sara Federico and Dr. Rajen Mody present results of a number of clinical trials looking at new treatments for relapsed disease. Dr. Steven DuBois rounds off the session with an overview of the multiple strategies underway to improve frontline treatments.
-
Need to speak with someone?Get in touch with our Family Support Team.
-
Help and supportHead to our Help and Support homepage to see how we can support you.
-
High-risk neuroblastomaFind all the relevant information for high-risk neuroblastoma in one place.
-
Clinical trialsLearn more about clinical trials as part of treatment for neuroblastoma.
Related videos
-
VideoUnderstanding current frontline treatment
Overview of how high-risk neuroblastoma is treated in the US and Europe, including current frontline approaches through COG and SIOPEN.
-
VideoTreating relapsed and refractory disease
An overview of clinical trials and new treatments for relapsed and refractory neuroblastoma.
-
VideoIf treatment doesn't go to plan
Explores care for relapsed and refractory neuroblastoma, alongside reflections on hope from a childhood cancer advocate.